{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:49:37Z","timestamp":1774486177007,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.anai.2015.04.015","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T09:17:43Z","timestamp":1431595063000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immediate-type hypersensitivity reactions due to antituberculosis drugs: a successful readministration protocol"],"prefix":"10.1016","volume":"115","author":[{"given":"G\u00f6zde K\u00f6yc\u00fc","family":"Buhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Keren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adile Berna","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcjgan","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcng\u00f6r","family":"Dulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilg\u00fcn","family":"Kala\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeref","family":"\u00d6zkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda \u00d6ner","family":"Erkekol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2015.04.015_bib1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2015.04.015_bib2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1183\/09031936.96.09102026","article-title":"Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis","volume":"9","author":"Schaberg","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2015.04.015_bib3","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.aids.0000391019.10661.66","article-title":"Adverse events with isoniazid preventive therapy: experience from a large trial","volume":"24","author":"Grant","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.anai.2015.04.015_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"G\u00fclbay","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2015.04.015_bib5","first-page":"868","article-title":"Adverse drug reactions associated with first-line anti-tuberculosis drug regimens","volume":"11","author":"Marra","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.anai.2015.04.015_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/pds.1468","article-title":"Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors","volume":"16","author":"Javadi","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.anai.2015.04.015_bib7","first-page":"143","article-title":"Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs","volume":"62","author":"Tan","year":"2007","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.anai.2015.04.015_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/eri.12.13","article-title":"Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future","volume":"10","author":"Lehloenya","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.anai.2015.04.015_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.iac.2014.03.002","article-title":"Drug allergy diagnosis","volume":"34","author":"Chiriac","year":"2014","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.anai.2015.04.015_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.04.015_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"26","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2015.04.015_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.04.015_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity\u2014a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.04.015_bib14","series-title":"Treatment of Tuberculosis. Guidelines. 4th ed. WHO\/HTM\/TB\/2009.420","year":"2010"},{"key":"10.1016\/j.anai.2015.04.015_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6061\/clinics\/2013(03)OA08","article-title":"Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil","volume":"68","author":"Damasceno","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.anai.2015.04.015_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/thx.2006.058867","article-title":"Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection","volume":"61","author":"Breen","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2015.04.015_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1258\/ijsa.2008.008361","article-title":"Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs","volume":"20","author":"Marks","year":"2009","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.anai.2015.04.015_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","article-title":"Cutaneous disease and drug reactions in HIV infection","volume":"328","author":"Coopman","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.04.015_bib19","first-page":"273","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Bernstein","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.04.015_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of an antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2015.04.015_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.iac.2009.04.008","article-title":"Provocation tests in drug hypersensitivity","volume":"29","author":"Aberer","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.anai.2015.04.015_bib22","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.5588\/ijtld.10.0698","article-title":"Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions","volume":"15","author":"Lehloenya","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.anai.2015.04.015_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/138955707782331740","article-title":"Overview of anti-tuberculosis drugs and their resistance mechanisms","volume":"7","author":"Shi","year":"2007","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.anai.2015.04.015_bib24","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1378\/chest.98.6.1518","article-title":"Rapid oral desensitization to isoniazid and rifampin","volume":"98","author":"Holland","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.anai.2015.04.015_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1034\/j.1398-9995.2003.00152.x","article-title":"Rapid oral desensitization to isoniazid, rifampin, and ethambutol","volume":"58","author":"Kim","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.04.015_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.aller.2009.05.006","article-title":"Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case","volume":"37","author":"Rodrigues Carvalho","year":"2009","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.anai.2015.04.015_bib27","doi-asserted-by":"crossref","first-page":"208797","DOI":"10.1155\/2013\/208797","article-title":"Hypersensitivity reaction and tolerance induction to ethambutol","volume":"2013","author":"Cernadas","year":"2013","journal-title":"Case Rep Med"},{"key":"10.1016\/j.anai.2015.04.015_bib28","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2169\/internalmedicine.49.3590","article-title":"Desensitization therapy for allergic reactions to antituberculous drugs","volume":"49","author":"Kobashi","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.anai.2015.04.015_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1164\/ajrccm.149.3.8118654","article-title":"Oral desensitization to rifampin and ethambutol in mycobacterial disease","volume":"149","author":"Matz","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2015.04.015_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000327537","article-title":"Pyrazinamide-induced anaphylaxis: diagnosed by skin test and successful desensitization","volume":"157","author":"Bavbek","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2015.04.015_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.aller.2010.12.008","article-title":"Rapid oral desensitization to prophylactic isoniazid","volume":"39","author":"Abadoglu","year":"2011","journal-title":"Allergol Immunopathol (Madr)"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615002677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615002677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:12:09Z","timestamp":1761052329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120615002677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1081120615002677"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2015.04.015","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate-type hypersensitivity reactions due to antituberculosis drugs: a successful readministration protocol","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2015.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}